ProfileGDS5822 / ILMN_2634702
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 85% 89% 88% 86% 88% 86% 87% 85% 85% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1255.685
GSM1276600PDAC Late Ablation Control 2433.889
GSM1276601PDAC Late Ablation Control 3438.588
GSM1276602PDAC Late Ablation 1266.286
GSM1276603PDAC Late Ablation 2402.388
GSM1276604PDAC Late Ablation 3318.686
GSM1303940PDAC Late Ablation_anti-CTLA4 1332.687
GSM1303941PDAC Late Ablation_anti-CTLA4 2316.385
GSM1303942PDAC Late Ablation_anti-CTLA4 3334.885